The DDF Ventures team combines all the skills and experience required to manage the fund and support the portfolio companies to become commercially successful.
Bart Wuurman, Managing Director and Portfolio Company CEO
As multiple entrepreneur Bart Wuurman has been CEO of ealy stage biotech companies for the last 12 years. He was instrumental to the profitable exits of three biotech companies; Lanthio Pharma and AM-Pharma in The Netherlands and Antisoma in the United Kingdom. He was involved in raising approximately € 80 million in equity and non-dilutive funding.
Before becoming CEO, Bart was VP Business Development and licensing for Antisoma plc and Medeva plc in the United Kingdom, where he was responsible for out-licensing deals worth over €700 million. Being trained as a pharmaceutical scientist, he started his career at Organon in The Netherlands. Apart from his executive roles, Bart is non-executive director for a number of life science companies, including the DDF Ventures portfolio companies and HollandBio, the Dutch association of Biotech companies.
Henk Viëtor, Founder and Portfolio Company CEO
Henk Viëtor is a medical doctor and scientists by training, specialized in clinical immunology, transfusion medicine and clinical genetics. His scientific results were published in numerous leading scientific journals including Nature. He is inventor on several patents.
Since he co-founded Drug Discovery Factory in 2000, he has been an active entrepreneur and co-founder of 10 Life Sciences start-up companies. He is also on the board of the Center for Translational Medicine.